Bio

Scott Sher is global co-chair of the Antitrust Practice Group and has represented companies before competition authorities in transactions collectively totaling more than $1 trillion over the past 20 years, including some of the highest-profile consolidation deals in the life sciences, technology and retail markets. Scott is lauded as a “true star of the antitrust bar” by Global Competition Review and ranked Band 1 for Antitrust by Chambers USA in Washington, D.C. Scott has counseled hundreds of clients with respect to antitrust issues that arise in the M&A process, including Google, Dolby, Trulia, Twitter, Southeastern Grocers, Northeastern Grocers, Careem, Seagate and Qualcomm, advocating before the U.S. Department of Justice, the Federal Trade Commission and global competition authorities. Beyond his decades of experience in clearance matters, Scott focuses on helping clients, whether buyers or sellers, assess potential antitrust risk early in the deal process, and putting them in the best position to understand and obtain the deal protection terms they need to meet their business objectives. Whether he is representing a small firm with promising technology being acquired by a large private equity firm with a competitor portfolio company, a large multinational client fending against a rival’s hostile tender offer, or a retailer selling a portion of its business to a competitor where the FTC may demand multiple divestitures, Scott helps his clients understand the most likely deal outcomes, strategize to maximize deal value and certainty of close, and position the transaction to close as expeditiously as possible. More broadly, Scott has unparalleled expertise in counseling clients on their business strategies. His work with companies across industries with different go-to-market strategies gives him a deep understanding of how antitrust laws impact his clients’ distribution, pricing, and licensing policies. This experience enables him to help clients efficiently achieve their objectives while steering them clear of potential liability. Specifically, Scott has guided major retail and technology firms in implementing pricing and distribution policies and guidelines in order to manage complex channel conflict issues, resale price maintenance concerns, exclusivity provisions and price bundling strategies. He also works with life science companies who often engage in intricate inbound and outbound licensing programs that include issues ranging from potential Hart-Scott-Rodino reportability to ensuring that firms competing with each other in therapeutic markets can maximize the impact of collaborative arrangements without running afoul of competition laws.